Rare diseases
Investigational molecules
Locations
Ul. Wladyslawa IV 59, 81-384 Gdynia, Poland
FutureMeds Gdynia in Gdynia, Poland specialises in clinical trials of conditions such as Obesity, Overweight, Psoriatic arthropathy, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.
FutureMeds Gdynia is conducting a broad program in cardiovascular disease to test innovative treatments that lower cholesterol, control blood pressure, and reduce the risk of heart attacks and strokes.
The studies aim to improve outcomes by evaluating new drugs that target lipid levels, blood pressure, and weight, with the ultimate goal of preventing major cardiovascular events.
The site’s immune system research focuses on autoimmune disorders, assessing novel biologics that may reduce disease activity and improve quality of life for patients.
These trials evaluate efficacy on clinical scores such as ACR and DAS, seeking safer and more effective therapeutic options.
Research in musculoskeletal health at FutureMeds Gdynia targets conditions that cause pain and bone loss, testing agents designed to restore function and strengthen bone.
The objectives include reducing joint pain, enhancing physical performance, and increasing bone mineral density through innovative therapies.
A dedicated effort on metabolic disease explores weight‑management strategies and diabetes care, evaluating compounds that promote weight loss and improve glucose control.
Trials are designed to demonstrate superiority of new agents over placebo in reducing body weight and lowering cardiovascular risk factors.
The clinic’s work in skin and connective tissue disorders includes testing therapies that address severe itching and inflammatory lesions.
Study goals focus on achieving meaningful itch relief and improving skin health through targeted biologic treatments.
FutureMeds Gdynia also runs studies on viral infections, evaluating antiviral drugs and vaccine combinations to protect high‑risk adults.
The trials aim to assess safety and effectiveness of new antivirals and to compare immune responses generated by combined vaccine formulations.
Clinical trials currently enrolling participants at this site.
Phase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
PolandEfficacy and Safety of Once‑Daily Oral ASC30 in Adults with Obesity or Overweight: A Phase III Randomized Placebo‑Controlled Trial
PolandA Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes
PolandA study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandA study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.
PolandStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
PolandStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
PolandPhase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease
PolandSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
PolandEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
PolandPhase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
